• The development of drugs and companion diagnostics requires the collection of rigorous and reliable chemical, pharmaceutical, and biological data. • Candidate gene association studies can identify ...
The concept of regulatory science is not a new one. The FDA Science Board’s 2007 Science and Mission at Risk report (FDA Science Board, 2007) describes regulatory science as a science-based ...
This executive summary focuses on dose-flexible manufacturing strategies and their role in drug development. Dose flexibility is increasingly important for early clinical studies, particularly in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results